. Biophys. Acta, 1202, 1
(1993).
4. Kosa, K., et al., Biochem. Biophys. Res Commun.,
196, 1025 (1993).
kaa/lpg 11/02
Sigma brand products are sold through Sigma-Aldrich
in mice with targeted
expression of a toxin gene to D1 dopamine receptor neurons. Neurosci 95(4):1025-1033.
Khan, Z. U. et al. (1998). Prominence of the dopamine d2 short isoform in dopaminergic
in mice with targeted
expression of a toxin gene to D1 dopamine receptor neurons. Neurosci 95(4):1025-1033.
Khan, Z. U. et al. (1998). Prominence of the dopamine d2 short isoform in dopaminergic
virus, spread along different neural pathways from the main olfactory bulb.
Neuroscience 57(4) : 1007-1025.
Ren, T. and Sagar (1992). Induction of c-fos immunostaining in the rat brain after the
systemic
771-5765
sigma-aldrich.com
Enabling Science to
Improve the Quality of Life
KEB
81107
1025
Physical Properties of Solvents
Peroxide Formation of Ether Solvent
Conditions
• 20 mL of
aminopropenoates; Efficient and versatile synthons for combinatorial synthesis of
heterocycles, Synthesis, 1025.
25. C. Y. Wu & C. M. Sun (2002) Parallel synthesis of 1,2,3,4-tetrahydro-beta-carbolines
using
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol
17. Cicalese, A., et al., Cell 138, 1083–1095 (2009).
18. Engels N et al., Nature Immunol. 9: 1018-1025 (2009).
19. Bantly, A.D., et al., Immunol. Invest., 36, 587-606 (2007).
20. Brusko, T. et al., Immunol